[go: up one dir, main page]

AU2001284189A1 - Modified release formulation - Google Patents

Modified release formulation

Info

Publication number
AU2001284189A1
AU2001284189A1 AU2001284189A AU8418901A AU2001284189A1 AU 2001284189 A1 AU2001284189 A1 AU 2001284189A1 AU 2001284189 A AU2001284189 A AU 2001284189A AU 8418901 A AU8418901 A AU 8418901A AU 2001284189 A1 AU2001284189 A1 AU 2001284189A1
Authority
AU
Australia
Prior art keywords
water
soluble
modified
modified release
polysaccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001284189A
Inventor
Jan-Erik Lofroth
Urban Skantze
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU2001284189A1 publication Critical patent/AU2001284189A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A pharmaceutical modified release formulation comprising a pharmacologically active substance and a modified water-soluble polysaccharide, which modified water-soluble polysaccharide is obtainable by: a) forming a precipitate of a water-soluble polysaccharide by contacting a solution of the water-soluble polysaccharide with a solvent in which the polysaccharide is poorly soluble or insoluble; or b) milling a water-soluble polysaccharide. The modified water-soluble polysaccharides provide modified release formulations with high tablet hardness. Also claimed are a process for preparing the modified release formulation, and the use of the modified water-soluble polysaccharides as an excipient in a pharmaceutical formulation.
AU2001284189A 2000-09-05 2001-08-30 Modified release formulation Abandoned AU2001284189A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0003125A SE0003125D0 (en) 2000-09-05 2000-09-05 Modified polymers
SE003125 2000-09-05
PCT/GB2001/003861 WO2002019990A1 (en) 2000-09-05 2001-08-30 Modified release formulation

Publications (1)

Publication Number Publication Date
AU2001284189A1 true AU2001284189A1 (en) 2002-03-22

Family

ID=20280889

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001284189A Abandoned AU2001284189A1 (en) 2000-09-05 2001-08-30 Modified release formulation

Country Status (9)

Country Link
US (1) US20040022850A1 (en)
EP (1) EP1322293B1 (en)
JP (1) JP2004508322A (en)
AT (1) ATE340564T1 (en)
AU (1) AU2001284189A1 (en)
DE (1) DE60123447T2 (en)
ES (1) ES2272527T3 (en)
SE (1) SE0003125D0 (en)
WO (1) WO2002019990A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0201661D0 (en) 2002-05-31 2002-05-31 Astrazeneca Ab New salts
SE0201659D0 (en) * 2002-05-31 2002-05-31 Astrazeneca Ab Modified release pharmaceutical formulation
ES2605414T3 (en) 2005-03-02 2017-03-14 Hercules Incorporated Water soluble hydroxyethylcellulose substitution of low, its derivatives, method of obtaining and its uses
BR112013000233A2 (en) 2010-07-28 2021-05-18 Dow Global Technologies Llc method of controlling or adjusting the release of an active ingredient and using a diluent control in a composition
CN109790226B (en) * 2016-09-29 2022-05-03 住友精化株式会社 Production method of water-soluble hydroxyethyl cellulose
WO2019183470A2 (en) 2018-03-22 2019-09-26 Incarda Therapeutics, Inc. A novel method to slow ventricular rate

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965256A (en) * 1972-05-16 1976-06-22 Synergistics Slow release pharmaceutical compositions
JPS5163927A (en) * 1974-11-28 1976-06-02 Shinetsu Chemical Co Ketsugoseiryokonajozaihokaizaino seizohoho
US4097606A (en) * 1975-10-08 1978-06-27 Bristol-Myers Company APAP Tablet containing an alkali metal carboxymethylated starch and processes for manufacturing same
US4063017A (en) * 1976-04-22 1977-12-13 Purdue Research Foundation Porous cellulose beads and the immobilization of enzymes therewith
US4024335A (en) * 1976-05-04 1977-05-17 Union Carbide Corporation Homogeneous hydroxy-alkylation of cellulose
AR241633A1 (en) * 1982-12-30 1992-10-30 Goemar Lab Sa New physiological product extracted from algae and plants, preparation method, extraction apparatus and applications
GB8613689D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
US4851233A (en) * 1986-10-06 1989-07-25 Warner-Lambert Company Sustained release formulations
FR2634397B2 (en) * 1986-12-31 1991-04-19 Centre Nat Rech Scient PROCESS FOR THE PREPARATION OF DISPERSIBLE COLLOIDAL SYSTEMS OF A PROTEIN IN THE FORM OF NANOPARTICLES
BR8806902A (en) * 1987-04-16 1989-10-31 Christian Bindschaedler PROCESS FOR PREPARING A POOL OF INSOLUBLE POLYMER IN WATER THAT MAY BE REDISPERSED IN A LIQUID PHASE, AS A RESULTING POINT AND ITS USE
US5004613A (en) * 1987-07-27 1991-04-02 Mcneil-Ppc, Inc. Oral sustained release pharmaceutical formulation and process
US4820522A (en) * 1987-07-27 1989-04-11 Mcneilab, Inc. Oral sustained release acetaminophen formulation and process
US5073380A (en) * 1987-07-27 1991-12-17 Mcneil-Ppc, Inc. Oral sustained release pharmaceutical formulation and process
US5066793A (en) * 1987-10-26 1991-11-19 Ciba-Geigy Corporation Finely particulate cellulose esters of aromatic or aromatic-aliphatic carboxylic acids, process for their preparation, and the use thereof
US4892739A (en) * 1988-04-25 1990-01-09 Ciba-Geigy Corporation Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having a improved core membrane adhesion properties
AT395724B (en) * 1990-12-07 1993-02-25 Chemiefaser Lenzing Ag METHOD FOR PRODUCING CELLULOSE MOLDED BODIES
US5550189A (en) * 1992-04-17 1996-08-27 Kimberly-Clark Corporation Modified polysaccharides having improved absorbent properties and process for the preparation thereof
EP0665010B1 (en) * 1992-10-16 2002-09-11 Nippon Shinyaku Company, Limited Method of manufacturing wax matrices
EP0676967A4 (en) * 1992-12-30 1996-10-02 Fmc Corp Readily available konjac glucomannan sustained release excipient.
US5451409A (en) * 1993-11-22 1995-09-19 Rencher; William F. Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
FI972305A7 (en) * 1994-12-01 1997-05-30 Cibus Pharmaceutical Inc NSAID administration using powdered hydrocolloid gum obtained from higher plants
JPH10509981A (en) * 1994-12-01 1998-09-29 サイバス ファーマシューティカル，インコーポレイティド Sustained drug delivery using powdered hydrocolloid rubber obtainable from higher plants
US6063402A (en) * 1995-06-07 2000-05-16 Venture Lending, A Division Of Cupertino National Bank Purified galactomannan as an improved pharmaceutical excipient
US6652882B1 (en) * 1997-10-06 2003-11-25 Intellipharmaceutics Corp Controlled release formulation containing bupropion

Also Published As

Publication number Publication date
ES2272527T3 (en) 2007-05-01
WO2002019990A1 (en) 2002-03-14
EP1322293A1 (en) 2003-07-02
US20040022850A1 (en) 2004-02-05
ATE340564T1 (en) 2006-10-15
SE0003125D0 (en) 2000-09-05
DE60123447T2 (en) 2007-08-23
JP2004508322A (en) 2004-03-18
DE60123447D1 (en) 2006-11-09
EP1322293B1 (en) 2006-09-27

Similar Documents

Publication Publication Date Title
PT1083884E (en) PROCESS FOR THE STABILIZATION OF POLYVINYL-PYRROLIDONE COMPOSITIONS
NZ527585A (en) Tablets quickly disintegrated in oral cavity
WO2007008752A3 (en) Sustained release pharmaceutical compositions for highly water soluble drugs
DK1149116T3 (en) Process for the preparation of multiple crosslinked hyaluronic acid derivatives
TNSN07290A1 (en) Gastroresistant pharmaceutical formulations containing rifaximin
PL335571A1 (en) Stabilisation of acid-sensitive benzimidazoles by combining them with amino acids and cyclodextrins
SE9904505D0 (en) Novel compounds
WO2003035051A3 (en) The use of proton sequestering agents in drug formulations
DE69924004D1 (en) ADMINISTRATION SYSTEM FOR WATER-INSOLUBLE MEDICINES
IL150528A0 (en) Ibuprofen containing active agent preparation
AU2001284189A1 (en) Modified release formulation
CN104173356A (en) Stabilized solid dispersion of adefovir dipivoxil and preparation method thereof
ATE286720T1 (en) PHARMACEUTICAL FORMULATIONS BASED ON SOLID DISPERSIONS
BR0013106A (en) Floating pharmaceutical composition, tablet, and tablet preparation process.
AU2001239625A1 (en) Method of preparing solid dispersions
ATE322891T1 (en) DRUG DELIVERY SYSTEM FOR WATER-SOLUBLE DRUGS
BR0012735A (en) Solid preparation and process for producing preparations
AU2003269792A1 (en) Pharmaceutical formulation of olanzapine
ES2174734A1 (en) Novel dispersible and soluble galenic paracetamol formulation, method for its preparation and its applications
NZ584968A (en) Novel antiretroviral combination comprising ritonavir and atazanavir
AU2002214223A1 (en) Long-acting cytokine derivatives and pharmaceutical compositions comprising them
NO20054417L (en) Process for the preparation of pharmaceutical preparations in the form of fibrate-containing tablets and the tablets thus prepared
WO2006034147A3 (en) Compositions and methods for the preparation and administration of poorly water soluble drugs
DK1144420T3 (en) Sulfated phosphatidylinositols, process for their preparation and uses thereof
ATE300293T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING POORLY SOLUBLE MEDICINAL SUBSTANCES